#USA #Miami #Women's Health #PMOS #SPHERE HEALTH

The Evolution of Women's Health Care: Introducing PMOS with SPHERE HEALTH

In recent developments, polycystic ovary syndrome (PCOS) has been officially rebranded as polyendocrine metabolic ovarian syndrome (PMOS). This change, effective from May, acknowledges the condition as a comprehensive hormonal and metabolic issue rather than solely an ovarian one. SPHERE HEALTH, a pioneering company in women's health, is harnessing this reconceptualization to launch a virtual care platform that recognizes the fluid nature of women's health across different life stages.

According to the Endocrine Society, PMOS affects approximately 1 in 8 women, totaling over 170 million globally. Alarmingly, nearly 40% of these women may develop prediabetes or type 2 diabetes by their early 40s. Additionally, the Mayo Clinic Health System reports that over 2 million American women enter menopause annually, translating to around 6,000 women daily. Yet, despite the prevalence of these conditions, healthcare services are often fragmented, with each life stage requiring a fresh beginning in treatment.

SPHERE HEALTH aims to address this issue by starting from the foundational aspects of hormonal and metabolic health, which impact a woman's overall well-being. The intricate connections between hormones, metabolism, cardiovascular health, sleep patterns, mood stability, and bone density shift significantly throughout a woman's life. By establishing a strong foundation in hormonal health, SPHERE HEALTH endeavors to provide a holistic perspective on women's health.

The innovative approach of SPHERE HEALTH involves a continuity of care that follows women through various health concerns such as PMOS, endometriosis, and metabolic health issues, extending into perimenopause and menopause. Each patient's history, assessment, and laboratory results are meticulously reviewed by board-certified OB-GYNs and physicians specialized in obesity medicine. Importantly, patients’ medical records are consistently maintained as they transition from one healthcare consultation to the next, avoiding the frequent need for women to start anew with each phase of their lives.

Pricing transparency is another hallmark of SPHERE HEALTH's new platform. The costs for new patients are clearly outlined:

• - Clarity: A one-time fee of $99 for a hormone and metabolic health lab panel curated to align with the individual’s care pathway, including physician review.
• - Continuum: A monthly subscription at $149, which encompasses ongoing consultations, tailored lab panels, a personalized care plan, and secure communication with physicians.
• - Constant: An all-inclusive option for $349 monthly that features everything within Continuum, expanded lab tests, home blood draws when possible, and the assistance of a dedicated Care Navigator.

When medications are part of a patient's care plan, this will be billed separately, ensuring a clear distinction between consultation fees and medicinal costs.

Dr. Mida Pezeshkian, Founder and CEO of SPHERE HEALTH, highlighted the company’s commitment to comprehensive women's health by stating, "Women don’t experience their health through the lens of isolated conditions. Hormonal factors influence every aspect of health, from metabolism to mood and heart function, adapting continuously through life stages. This is why we emphasize hormonal health; getting it right allows us to see the complete picture of women’s health and effectively cater to their needs throughout all phases of their lives."

At the core of each individualized care plan lies 'Rosalyn,' the intelligent platform named after Nobel laureate Rosalyn Yalow, who pioneered hormone measurement in blood. Rosalyn utilizes AI technology to integrate a woman’s lab results, medical history, and assessments into a unified view that enhances the insights available for her physician. This organized approach ensures that the physician is presented with a comprehensive overview before making care decisions.

Starting today, SPHERE HEALTH opens its doors to early access via a waiting list, allowing women to join at spherehealth.com. However, it's important to note that services are not yet operational in Hawaii or Rhode Island. As SPHERE HEALTH expands its offerings, the company aims to continually enhance women's health care in a manner that respects and reflects the complexities of their lived experiences.

In conclusion, as SPHERE HEALTH pioneers this transformative approach to addressing hormonal health across various stages, it signifies a much-needed shift in the women’s health landscape, prioritizing a holistic and integrated model of care for patients worldwide.